![]() Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. | ![]() Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry. | ||
Founding Date | Founding Date 2000 | Founding Date 1995 | Founding Date 2014 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Wayne, US HQ San Francisco, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Cambridge, US HQ |
Employees | Employees 1418% decrease | Employees 20216% increase | Employees 40323% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 737.4 m | Valuation ($) 1.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $67.7m (FY, 2025) |
Net income | Net income ($30.8m) (FY, 2018) | Net income ($50.3m) (FY, 2025) | Net income ($412.7m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 7m | Total funding raised $ 244.7m | Total funding raised N/A |

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View company
Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.
View company